DexCom Inc. (DXCM)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
Lee Ainslie - Maverick Capital Sell 100.00% 16,664 0.04
Chase Coleman - Tiger Global Management Sell 100.00% 1,152,806 0.60
Q2  2024
Lee Ainslie - Maverick Capital Buy 16,664 0.04
Q1  2024
Lee Ainslie - Maverick Capital Sell 100.00% 4,876 0.01
Q4  2023
Lee Ainslie - Maverick Capital Reduce 58.54% 6,885 0.01
Chase Coleman - Tiger Global Management Buy 1,152,806 1.02
Q3  2023
Lee Ainslie - Maverick Capital Buy 11,761 0.03
Q4  2021
Stephen Mandel - Lone Pine Capital Sell 100.00% 5,764,908 2.66
Q3  2021
Lee Ainslie - Maverick Capital Sell 100.00% 844 0.00
Stephen Mandel - Lone Pine Capital Reduce 22.86% 1,708,240 0.79
Q2  2021
Lee Ainslie - Maverick Capital Reduce 92.82% 10,912 0.00
Stephen Mandel - Lone Pine Capital Reduce 21.27% 2,019,444 0.69
Q1  2021
Lee Ainslie - Maverick Capital Add 1021.76% 10,708 0.01
Stephen Mandel - Lone Pine Capital Add 4.64% 421,356 0.14
Q4  2020
Lee Ainslie - Maverick Capital Reduce 27.62% 400 0.00
Stephen Mandel - Lone Pine Capital Add 389.72% 7,218,888 2.43
Q3  2020
Lee Ainslie - Maverick Capital Buy 1,448 0.00
Stephen Mandel - Lone Pine Capital Add 36.38% 494,164 0.22
Q2  2020
Stephen Mandel - Lone Pine Capital Buy 1,358,184 0.71
Q1  2020
Stephen Mandel - Lone Pine Capital Sell 100.00% 4,235,580 1.24
Q4  2019
Stephen Mandel - Lone Pine Capital Buy 4,235,580 1.24

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.